Spyre Therapeutics, Inc.

MORGAN STANLEY SYRE

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

3,306

Value ($000)

1

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	1	0.0%	3,306	6/30/2023
2023 Q1	5/15/2023	4	0.0%	13,656	3/31/2023
2022 Q4	2/14/2023	36	0.0%	80,461	12/31/2022
2022 Q3	11/14/2022	88	0.0%	168,258	9/30/2022
2022 Q2	10/27/2022	148	0.0%	293,834	6/30/2022
2022 Q1	10/27/2022	418	0.0%	181,701	3/31/2022
2021 Q4	2/14/2022	932	0.0%	196,218	12/31/2021
2021 Q3	11/15/2021	1,544	0.0%	194,225	9/30/2021
2021 Q2	8/23/2021	1,362	0.0%	195,535	6/30/2021
2021 Q1	5/17/2021	880	0.0%	111,090	3/31/2021
2020 Q4	2/16/2021	1,008	0.0%	128,090	12/31/2020
2020 Q3	11/13/2020	249	0.0%	35,091	9/30/2020
2020 Q2	8/14/2020	235	0.0%	25,467	6/30/2020
2020 Q1	5/26/2020	16	0.0%	3,457	3/31/2020
2019 Q4	2/14/2020	276	0.0%	36,127	12/31/2019